BENIGN BONE NEOPLASM

This adverse event was reported 209 times

These drugs are most commonly taken by patients reporting BENIGN BONE NEOPLASM:

# Drug Count
0 ADALIMUMAB 29
1 ALENDRONATE SODIUM 19
2 GABAPENTIN 19
3 PREDNISONE 19
4 INTERFERON BETA-1A 16
5 ACETAMINOPHEN 15
6 ESOMEPRAZOLE MAGNESIUM 12
7 LEVOTHYROXINE SODIUM 12
8 OMEPRAZOLE MAGNESIUM 12
9 ATENOLOL 11
See all common drugs associated with BENIGN BONE NEOPLASM

BENIGN BONE NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DIFLORASONE DIACETATE 1 0.0052
1 FERROUS ASPARTO GLYCINATE, IRON, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, AND SUCCINIC ACID 2 0.0033
2 DIFLUNISAL 1 0.0012
3 DIMENHYDRINATE 9 0.0008
4 FAMOTITINE 2 0.0007
5 1168 BURN SPRAY 2 0.0007
6 CEFACLOR 1 0.0006
7 CALCITONIN SALMON 2 0.0006
8 ALLANTOIN 2 0.0006
9 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 6 0.0005
See all drugs enriched for association with BENIGN BONE NEOPLASM

BENIGN BONE NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 2 0.0006
1 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
2 alpha-Hydroxy Acid [EPC] 1 0.0005
3 Provitamin D2 Compound [EPC] 11 0.0004
4 Bismuth [EPC] 2 0.0004
5 Plasma Volume Expander [EPC] 1 0.0003
6 GLP-2 Analog [EPC] 4 0.0003
7 Blood Viscosity Reducer [EPC] 1 0.0002
8 Aluminum Complex [EPC] 4 0.0002
9 Stimulant Laxative [EPC] 2 0.0001
See all drug classes enriched for association with BENIGN BONE NEOPLASM